Christine Kretz

Illkirch-graffenstaden, 67404, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Lack of myotubularin phosphatase activity is the main cause of X-linked myotubular myopathy.

Lack of myotubularin phosphatase activity is the main cause of X-linked myotubular myopathy.

Journal: JCI insight

Published: November 15, 2024

BIN1 modulation in vivo rescues dynamin-related myopathy.

BIN1 modulation in vivo rescues dynamin-related myopathy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 18, 2022

Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice.

Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice.

Journal: JCI insight

Published: June 01, 2021

Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.

Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 04, 2021

Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.

Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 08, 2021

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin.

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin.

Journal: JCI insight

Published: March 05, 2020

Differential physiological roles for BIN1 isoforms in skeletal muscle development, function and regeneration.

Differential physiological roles for BIN1 isoforms in skeletal muscle development, function and regeneration.

Journal: Disease models & mechanisms

Published: February 27, 2020

Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients.

Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients.

Journal: Molecular therapy. Methods & clinical development

Published: February 17, 2020

Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy.

Reducing dynamin 2 (DNM2) rescues DNM2-related dominant centronuclear myopathy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 07, 2018

Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.

Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.

Journal: Science translational medicine

Published: August 22, 2018

Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.

Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 17, 2017

Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.

Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.

Journal: Human molecular genetics

Published: March 05, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026